# Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia

> **NCT03283228** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 30 (estimated)

## Conditions studied

- Adult Acute Myeloid Leukemia

## Interventions

- **DIAGNOSTIC_TEST:** Cd11b and Cd56 markers

## Key facts

- **NCT ID:** NCT03283228
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03283228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03283228, "Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03283228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*